Tumor angiogenesis is the process of growing new blood vessels that can assist cancerous growths through the supply of nutrients and oxygen as well as removing waste products.
fluorescence lifetime imaging (FLIM) mapping, single and two-photon fluorescence excitation, lifetime components and corresponding decay profiles were used as parameters able to investigate qualitatively the cellular behavior regarding the molecular environment and biolocalisation of TrpNDI and 15
TrpNDI-RGDfK in cancer cells.
Tumor angiogenesis is the process of growing new blood vessels that can assist cancerous growths through the supply of nutrients and oxygen as well as removing waste products. 1 Angiogenesis is 20 an important feature of the spread of a tumor, given that single cancer cells can escape into blood vessels and can also be transported to distant sites, 2 thus generating secondary tumors. Angiogenesis is a potential target for combating cancer as it plays a key role in tumor metastasis and growth. The use of specific 25 compounds that may inhibit new blood vessels formation at the tumor site may help to switch off the metastasis, but their intimate behavior at the cellular level remains a matter of intense investigations: as such, the αvβ3 integrin peptide is one of the most important molecular markers involved in the mechanism of cell 30 adhesion to the extracellular matrix (ECM). The integrin is highly expressed during angiogenesis and plays an important role in transferring signals from the extra-cellular environment to the intracellular compartment. 3 The αvβ3 integrin is absent in resting endothelial cells and most normal organ systems, rendering it a 35 potential target for anti-angiogenic cancer therapy. Tumor progression and metastasis of breast cancer, glioma, melanoma and ovarian carcinoma are all linked to αvβ3 integrin overexpression during tumor angiogenesis. It has been found that several proteins such as vitronectin, fibrinogen and fibronectin can bind to αvβ3 40 integrin via the same amino acid sequence arginine-glycine-aspartic acid, or RGD. 4 It has been shown that cyclo(RGDfK) is one of the most prominent structures for development of molecular imaging agents for the assessment of αvβ3 expression. This pentapeptide, cyclo(-Arg-Gly-Asp-DPhe-Val-), was developed by Kessler and 45 co-workers to show high affinity and selectivity for αvβ3 integrin. 5 We, and others, have studied the supramolecular chemistry of functionalised naphthalene diimides: NDI molecules have attracted considerable attention recently because of excellent electron accepting properties and solubility in biocompatible media as well 50 as organic solvents [6] [7] . NDIs and their derivatives are flat, aromatic molecules which have fluorescent properties, suitable for singleand two-photon cellular imaging and are easily functionalisable with amino acids.
7 These make NDI derivatives attractive candidates as building blocks for optical imaging probes, 55 particularly as NDIs have strong absorption and fluorescence emissions in the visible and near-IR wavelengths. Previous work on aminoacid-functionalised NDIs showed that, despite quantum yields that rather low in aqueous media (less than 0.005 with respect to [Ru(bipy)3PF6]' likely due to non-radiative decay 60 pathways emerging from aromatic stacking and internal hydrogen bonds) 8 , such materials are taken up by cancer cells in preference with respect to healthy cells. Here, the first NDI-peptide imaging probe incorporating a cancer specific targeting peptide (cyclic RGDfK) and an amino acid (L-Trp) was designed and synthesised 65 in two simple synthetic steps through the EDC-mediated coupling to the strongly fluorescent tryptophan-NDI, which emits broadly in both single-and two-photon excitation with maxima above 500 nm. To shed light into the fate of bio/medical imaging probes in a cellular environment, the uptake of the new compounds 2 and 4 shown in Scheme 1 was investigated using Fluorescence Lifetime
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Imaging Microscopy (FLIM) coupled with multiphoton confocal fluorescence microscopy: this combination of methods, together with MTT assays already provided reliable means to probe directly the environmental effects upon uptake and biolocalisation of aromatic compounds as probes inside living cells.
7b, [8] [9] The cyclo-(RGDfK) was chosen in particular for the potential to 5 selectively bind to prostate cancer cells that overexpress the specific target receptor. Furthermore, the NDIs plus cyclo-(RGDfK) conjugates were used to image cancer cells in vitro.
A series of purpose-made RGDfK peptides were synthesised on a laboratory scale using a standard Fmoc solid phase synthesis 10 protocol, as described in ESI. The resulting cyclic peptide 3 was successfully isolated and characterised by 1 H NMR in d 6-DMSO (including NOESY to verify cyclisation), ESI/MS, MALDI and HPLC. A new compound, tryptophan substituted NDI (TrpNDI, compound 2) was synthesised from L-Tryptophan and 1, 4, 5, [8] [9] [10] [11] [12] [13] [14] [15] naphtalenetetracarboxylic dianhydride (1), using a rapid and straightforward microwave-assisted method (Scheme 1), in almost quantitative yield. The molecular structure and supramolecular self-assembly of TrpNDI (2) was determined in the solid state by single crystal X-ray crystallography ( Figure 1 ).
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Crystals suitable for analysis were grown from DMSO and synchrotron single crystal X-ray diffraction data was obtained for 2. The molecules are held together in a hydrogen bonded network formed between the tryptophan NH of one molecule and the carboxylic carbonyl C=O from neighbouring molecules (N1···O2 25 2.868 Å, 162.3°; N4···O7 2.862 Å, 168.4°). This supramolecular structure is further reinforced by π-π donor-acceptor interactions between the tryptophan residue and the NDI core (avg. π···π distance 3.233Å, with a 5.9° angle between the two avg. π planes). The carboxylic OH is involved in hydrogen bond 30 interactions with the solvent molecules (DMSO and H2O). Crystal data and structure refinement parameters are included in ESI. With compound 2 in hand, the corresponding NDI-RGDfK conjugate (TrpNDI-RGDfK, 4) was synthesised by coupling the EDC-functionalised TrpNDI intermediate (compound 2a, described 45 in ESI) to the amino group of lysine residue of the deprotected cyclic peptide RGDfK (compound 3, as shown in Scheme 1 and described in ESI). The novel NDI-peptide conjugate (TrpNDIRGDfK) was purified and isolated by semi preparative-HPLC on a milligram scale and characterised by MALDI mass spectrometry 50 (given in ESI).
The quantum yield of TrpNDI (2) was determined to be 0.002 in DMSO, with fluorescein in aqueous 0.1 M NaOH as the reference 10 . This was in line with that found for related NDIs in aqueous environments and, since earlier studies on NDIs and 55 related molecules showed that this does hamper the cellular tracing by multiphoton confocal fluorescence imaging, fluorescence lifetime imaging microscopy (FLIM) and confocal laser scanning microscopy were utilised as the imaging tools of choice for the investigations into the probe behavior in living cells. Furthermore, 60 MTT assays (ESI) showed that at concentrations of ca. 100 μM both compounds 2 and 4 are biocompatible within 48 h observation time towards both FEK-4 (a healthy cell line) and PC-3 (prostate cancer cell line). ESI describes in full the results of the cellular viability assays. The stability of 4 with respect to decomposition 65 and the retention of corresponding in vitro fluorescence emissions were probed in living cells for both TrpNDI (2) and TrpNDIRGDfK (4). In order to detect TrpNDI (2) and its RGDfK derivative (4) inside cancer cells, FLIM was used here for mapping the lifetime of the fluorophores' emission and also to shed light 70 upon their cellular biodistribution: this was found, in control experiments (described in ESI) to be significantly removed from cellular autofluorescence. Interestingly, unlike related NDIs, compounds 2 and 4 do not localise in the cells' nuclei but throughout the cytoplasm. Two photon imaging experiments were carried out given that 10 standard dyes co-staining assays were not conclusive in pinpointing specific organelles for dyes' biolocalisation. To investigate the effect of the environment on the new probes, lifetime measurements were recorded using time-correlated single photon counting with an excitation wavelength of 810 nm and the emission Both TrpNDI 2 and TrpNDI-RGDfK 4 (10 mM stock solutions in DMSO, 2P excitation 810 nm) were found to decay as two component systems, with minor components (τ2) in the order of 40 several nanoseconds and major components (τ1) in the order of several hundred picoseconds (Table 1 ). In DMSO, at 100 μM Compound 2 was also found to decay as a three component system, with a τ1 of 0.1 ns (50%), with a τ2 of 0.7 ns (22.8%) and a τ3 of 3.2 ns (27.2%), the χ 2 was 1.18. The TSPC spectrum of TrpNDI-
45
RGDfK displays a very close decay behavior to that of TrpNDI (Table 1 , Figure 4 and ESI) and in both cases evidence of some aggregation (in line with the X-ray structure observations, Figure 1 ) may account for the extremely short lifetime components present. Next, living PC-3 cells were plated on Petri dishes incorporating 50 a glass cover slip and allowed to adhere for 12 h. Background lifetime readings were recorded using fluorescence lifetime imaging microscopy (FLIM) before the addition of compound. The Petri dishes containing the cells were then mounted on the microscope stage and kept at 37 °C during imaging, which was 55 performed immediately. Compounds 2 and 4 were dissolved in DMSO and added to the cells to achieve a final concentration of dye of 100 μM in EMEM Table 2) . This confirms that the compounds do indeed enter the cells, and in line with single photon CLSM measurements, both 2 and 4 predominantly localise within the cytoplasm with negligible nuclear uptake, unlike the related iodine-fundtionalised L-phenyl 85 alanine NDI reported earlier. 8 Interestingly, although both 2 and 4 are biocompatible with the living cells used hereby within the imaging experiments' timescales, they exhibit different fluorescence lifetime values, but which are comparable with those resulting from the solution experiments and also show 90 clearly distinct cellular distributions in vitro. This is not surprising given the presence of the RDG targeting peptide in 4, molecular size and shape differences and the fact that compound 4 is more likely than 2 to form large lipophilic cations upon protonation. We thank the University of Bath and EPSRC for studentships (ZH, JAT, RLA) 
